Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells
- PMID: 38393411
- DOI: 10.1007/s12032-024-02329-1
Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells
Abstract
Breast cancer progression, metastasis and recurrence are largely driven by breast cancer stem cells (BCSCs), which constitute a subset of tumor cells exhibiting stem cell characteristics. In this study, we evaluated the role of estrogen-related receptor alpha (ERRα) in the migration, invasion and angiogenesis of BCSCs. The inhibition of ERRα using XCT790 or knockdown of ERRα using shRNA inhibited the mammosphere formation efficiency, as well as the migration and invasion of BCSCs derived from the mammospheres of MCF7 and MDA-MB-231 (MB231) cells. Conversely, the overexpression of ERRα significantly increased the migration and invasion of BCSCs derived from the mammosphere. In addition, the XCT790 treatment or shERRα significantly downregulated the epithelial-mesenchymal transition (EMT), as evidenced by the downregulation in the expression of vimentin, Snail, Slug and N-cadherin in the mammospheres of MCF7 and MB231 cells. The chorioallantoic membrane assay showed that the conditioned media from XCT790-treated and shERRα cells significantly inhibited blood vessel formation and vessel length. Furthermore, XCT790 treatment or shERRα also downregulated the expression of molecular markers of angiogenesis, such as VEGF-A and Ang-2 in the mammospheres. Conversely, the overexpression of ERRα in MCF7 cells significantly increased both EMT and angiogenesis. These findings suggest that ERRα inhibits the migration, invasion and angiogenesis of BCSCs, suggesting as a potential target for breast cancer therapy.
Keywords: Breast cancer; Cancer stem cells; Estrogen-related receptor α; Invasion; Migration; XCT790.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Similar articles
-
Estrogen-Related Receptor Alpha (ERRα) Promotes Cancer Stem Cell-Like Characteristics in Breast Cancer.Stem Cell Rev Rep. 2023 Nov;19(8):2807-2819. doi: 10.1007/s12015-023-10605-2. Epub 2023 Aug 16. Stem Cell Rev Rep. 2023. PMID: 37584854
-
Anti-metastasis activity of curcumin against breast cancer via the inhibition of stem cell-like properties and EMT.Phytomedicine. 2019 May;58:152740. doi: 10.1016/j.phymed.2018.11.001. Epub 2018 Nov 12. Phytomedicine. 2019. PMID: 31005718
-
Antitumor effect of XCT790, an ERRα inverse agonist, on ERα-negative endometrial cancer cells.Cell Oncol (Dordr). 2019 Apr;42(2):223-235. doi: 10.1007/s13402-019-00423-5. Epub 2019 Jan 31. Cell Oncol (Dordr). 2019. PMID: 30706380
-
Downregulation of estrogen-related receptor alpha inhibits human cutaneous squamous cell carcinoma cell proliferation and migration by regulating EMT via fibronectin and STAT3 signaling pathways.Eur J Pharmacol. 2018 Apr 15;825:133-142. doi: 10.1016/j.ejphar.2018.02.025. Epub 2018 Feb 21. Eur J Pharmacol. 2018. PMID: 29476880
-
Inhibition of ERRα suppresses epithelial mesenchymal transition of triple negative breast cancer cells by directly targeting fibronectin.Oncotarget. 2015 Sep 22;6(28):25588-601. doi: 10.18632/oncotarget.4436. Oncotarget. 2015. PMID: 26160845 Free PMC article.
References
-
- Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49. https://doi.org/10.3322/caac.21660 . - DOI - PubMed
-
- Van Mechelen M, Van Herck A, Punie K, Nevelsteen I, Smeets A, Neven P, et al. Behavior of metastatic breast cancer according to subtype. Breast Cancer Res Treat. 2020;181:115–25. https://doi.org/10.1007/s10549-020-05597-3 . - DOI - PubMed
-
- van Maaren MC, de Munck L, Strobbe LJA, Sonke GS, Westenend PJ, Smidt ML, et al. Ten-year recurrence rates for breast cancer subtypes in the Netherlands: a large population-based study. Int J Cancer. 2019;144:263–72. https://doi.org/10.1002/ijc.31914 . - DOI - PubMed
-
- Welch DR, Hurst DR. Defining the hallmarks of metastasis. Cancer Res. 2019;79:3011–27. https://doi.org/10.1158/0008-5472.CAN-19-0458 . - DOI - PubMed - PMC
-
- Ayob A, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25:20. https://doi.org/10.1186/s12929-018-0426-4 . - DOI - PubMed - PMC
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous